Michael A. Carlock

579 total citations
28 papers, 303 citations indexed

About

Michael A. Carlock is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Michael A. Carlock has authored 28 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 12 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Michael A. Carlock's work include Influenza Virus Research Studies (23 papers), Respiratory viral infections research (7 papers) and Immune Response and Inflammation (5 papers). Michael A. Carlock is often cited by papers focused on Influenza Virus Research Studies (23 papers), Respiratory viral infections research (7 papers) and Immune Response and Inflammation (5 papers). Michael A. Carlock collaborates with scholars based in United States, Singapore and Australia. Michael A. Carlock's co-authors include Ted M. Ross, Harry Kleanthous, Richard K. Zimmerman, Moti Ramgopal, James D. Allen, Eric M. Bachelder, Kristy M. Ainslie, Krissy Moehling Geffel, Cole J. Batty and Christine Vogel and has published in prestigious journals such as ACS Nano, The Journal of Immunology and PLoS ONE.

In The Last Decade

Michael A. Carlock

25 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Carlock United States 10 180 123 100 83 33 28 303
Rodrigo B. Abreu United States 10 180 1.0× 125 1.0× 125 1.3× 77 0.9× 57 1.7× 14 348
Wilbur Chen United States 4 157 0.9× 109 0.9× 58 0.6× 99 1.2× 23 0.7× 6 333
Caroline L. Ashley Australia 9 91 0.5× 140 1.1× 93 0.9× 100 1.2× 18 0.5× 15 300
Dennis Lapuente Germany 12 93 0.5× 139 1.1× 117 1.2× 74 0.9× 16 0.5× 22 286
April Killikelly Canada 8 154 0.9× 52 0.4× 88 0.9× 86 1.0× 11 0.3× 21 281
Maddy L. Newby United Kingdom 13 71 0.4× 88 0.7× 225 2.3× 107 1.3× 52 1.6× 19 369
Neha Quadir India 10 199 1.1× 73 0.6× 239 2.4× 114 1.4× 8 0.2× 14 354
Venkatramanan Mohanram United States 12 65 0.4× 229 1.9× 61 0.6× 87 1.0× 16 0.5× 17 356
Keisuke Tonouchi Japan 6 132 0.7× 138 1.1× 134 1.3× 74 0.9× 49 1.5× 11 292

Countries citing papers authored by Michael A. Carlock

Since Specialization
Citations

This map shows the geographic impact of Michael A. Carlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Carlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Carlock more than expected).

Fields of papers citing papers by Michael A. Carlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Carlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Carlock. The network helps show where Michael A. Carlock may publish in the future.

Co-authorship network of co-authors of Michael A. Carlock

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Carlock. A scholar is included among the top collaborators of Michael A. Carlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Carlock. Michael A. Carlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stacey, Hannah D., Michael A. Carlock, James D. Allen, et al.. (2025). Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the post-vaccination response. EBioMedicine. 116. 105744–105744.
2.
Pickering, Harry, Michael A. Carlock, Monica Cappelletti, et al.. (2025). Elevated NK and T cell-associated cytokines in plasma are associated with serological response to influenza vaccination. Frontiers in Immunology. 16. 1662942–1662942.
3.
Carlock, Michael A., et al.. (2025). Induction of Antigen-Specific Tolerance in a Multiple Sclerosis Model without Broad Immunosuppression. ACS Nano. 19(3). 3764–3780. 2 indexed citations
4.
Aban, Malet, Michelle Wille, Natalie Spirason, et al.. (2024). Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin. Nature Microbiology. 9(8). 2073–2083. 9 indexed citations
5.
6.
Ma, Yutian, Michael A. Carlock, Ted M. Ross, et al.. (2024). Polymeric cGAMP microparticles affect the immunogenicity of a broadly active influenza mRNA lipid nanoparticle vaccine. Journal of Controlled Release. 372. 168–175. 8 indexed citations
7.
Pushalkar, Smruti, Shuvadeep Maity, Ted M. Ross, et al.. (2024). Complex changes in serum protein levels in COVID-19 convalescents. Scientific Reports. 14(1). 4479–4479. 5 indexed citations
8.
Lifshits, Liubov M., Cole J. Batty, Michael A. Carlock, et al.. (2023). Zinc Carnosine Metal–Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability. Molecular Pharmaceutics. 20(9). 4687–4697. 6 indexed citations
9.
Carlock, Michael A., et al.. (2023). Urine Metabolome Dynamics Discriminate Influenza Vaccination Response. Viruses. 15(1). 242–242. 5 indexed citations
10.
11.
Dzimianski, John V., Julianna Han, Giuseppe A. Sautto, et al.. (2023). Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine. Communications Biology. 6(1). 454–454. 9 indexed citations
12.
Batty, Cole J., John A. Roque, Michael A. Carlock, et al.. (2023). Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG. Frontiers in Immunology. 14. 1103765–1103765. 7 indexed citations
13.
Carlock, Michael A. & Ted M. Ross. (2023). A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages. Scientific Reports. 13(1). 15911–15911. 13 indexed citations
14.
Batty, Cole J., Liubov M. Lifshits, Michael A. Carlock, et al.. (2023). Vinyl Sulfone-functionalized Acetalated Dextran Microparticles as a Subunit Broadly Acting Influenza Vaccine. The AAPS Journal. 25(1). 22–22. 11 indexed citations
15.
Carlock, Michael A., et al.. (2023). Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations. Bioengineering & Translational Medicine. 9(2). e10634–e10634. 7 indexed citations
16.
Forst, Christian V., Matthew Wai Heng Chung, Lauren Lashua, et al.. (2022). Vaccination History, Body Mass Index, Age, and Baseline Gene Expression Predict Influenza Vaccination Outcomes. Viruses. 14(11). 2446–2446. 8 indexed citations
17.
Chen, Xuemin, He-Ying Sun, Chun‐Yi Lee, et al.. (2022). Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination. Virology. 569. 44–55. 4 indexed citations
18.
Ross, Ted M., et al.. (2022). Evaluation of determinants of the serological response to the quadrivalent split‐inactivated influenza vaccine. Molecular Systems Biology. 18(5). e10724–e10724. 13 indexed citations
19.
Li, Lei, Yoshikazu Honda‐Okubo, Ying Huang, et al.. (2021). Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection. Vaccine. 39(40). 5940–5953. 58 indexed citations
20.
Nuñez, Ivette A., Michael A. Carlock, James D. Allen, et al.. (2017). Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains. PLoS ONE. 12(11). e0185666–e0185666. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rodrigo B. Abreu Breakdown of academic impact, for papers by Wilbur Chen Breakdown of academic impact, for papers by Caroline L. Ashley Breakdown of academic impact, for papers by Dennis Lapuente Breakdown of academic impact, for papers by April Killikelly Breakdown of academic impact, for papers by Maddy L. Newby Breakdown of academic impact, for papers by Neha Quadir Breakdown of academic impact, for papers by Venkatramanan Mohanram Breakdown of academic impact, for papers by Keisuke Tonouchi
Rankless by CCL
2026